Sunzen Group Berhad Past Earnings Performance

Past criteria checks 4/6

Sunzen Group Berhad has been growing earnings at an average annual rate of 66.1%, while the Personal Products industry saw earnings growing at 8.8% annually. Revenues have been declining at an average rate of 25.3% per year. Sunzen Group Berhad's return on equity is 4.7%, and it has net margins of 6.3%.

Key information

66.1%

Earnings growth rate

65.5%

EPS growth rate

Personal Products Industry Growth8.3%
Revenue growth rate-25.3%
Return on equity4.7%
Net Margin6.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations

Nov 07
Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations

Recent updates

Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise

Dec 12
Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise

Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations

Nov 07
Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations

Sunzen Biotech Berhad's (KLSE:SUNZEN) Shareholders Might Be Looking For Exit

Oct 15
Sunzen Biotech Berhad's (KLSE:SUNZEN) Shareholders Might Be Looking For Exit

Sunzen Biotech Berhad's (KLSE:SUNZEN) Returns On Capital Are Heading Higher

Aug 06
Sunzen Biotech Berhad's (KLSE:SUNZEN) Returns On Capital Are Heading Higher

If EPS Growth Is Important To You, Sunzen Biotech Berhad (KLSE:SUNZEN) Presents An Opportunity

May 25
If EPS Growth Is Important To You, Sunzen Biotech Berhad (KLSE:SUNZEN) Presents An Opportunity

Optimistic Investors Push Sunzen Biotech Berhad (KLSE:SUNZEN) Shares Up 27% But Growth Is Lacking

May 24
Optimistic Investors Push Sunzen Biotech Berhad (KLSE:SUNZEN) Shares Up 27% But Growth Is Lacking

Sunzen Biotech Berhad (KLSE:SUNZEN) Is Doing The Right Things To Multiply Its Share Price

Apr 22
Sunzen Biotech Berhad (KLSE:SUNZEN) Is Doing The Right Things To Multiply Its Share Price

Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Nov 16
What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?

Mar 26
Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?

Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?

Dec 10
Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?

Revenue & Expenses Breakdown

How Sunzen Group Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KLSE:SUNZEN Revenue, expenses and earnings (MYR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24956130
31 Dec 23987180
30 Sep 23865130
30 Jun 23844130
31 Mar 23924140
31 Dec 22974150
30 Sep 221093120
30 Jun 221032120
31 Mar 22952120
31 Dec 21901110
30 Sep 2189-9190
30 Jun 2192-9180
31 Mar 2185-11160
31 Dec 2082-13170
30 Sep 2099-17110
30 Jun 20141-20140
31 Mar 20195-20140
31 Dec 19241-18150
30 Sep 19270-13160
30 Jun 19307-11140
31 Mar 19292-8130
31 Dec 18296-7100
30 Sep 18325190
30 Jun 18304370
31 Mar 18329260
31 Dec 17303350
30 Sep 17214640
30 Jun 17144440
31 Mar 1778250
31 Dec 1640060
30 Sep 1635-380
30 Jun 1633-380
31 Mar 1632-270
31 Dec 1532060
30 Sep 1534160
30 Jun 1536160
31 Mar 1537170
31 Dec 1437170
30 Sep 1438290
30 Jun 1439390
31 Mar 1438380
31 Dec 1337470

Quality Earnings: SUNZEN has high quality earnings.

Growing Profit Margin: SUNZEN's current net profit margins (6.3%) are higher than last year (5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SUNZEN has become profitable over the past 5 years, growing earnings by 66.1% per year.

Accelerating Growth: SUNZEN's earnings growth over the past year (43.5%) is below its 5-year average (66.1% per year).

Earnings vs Industry: SUNZEN earnings growth over the past year (43.5%) exceeded the Personal Products industry 10.4%.


Return on Equity

High ROE: SUNZEN's Return on Equity (4.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:12
End of Day Share Price 2024/12/26 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sunzen Group Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution